Tenet Healthcare (THC) PT Raised to $40 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Tenet Healthcare (THC) PT Raised to $30 at RBC Capital
May 2, 2018 8:45 AM EDTRBC Capital raised its price target on Tenet Healthcare (NYSE: THC) to $30.00 (from $21.00) while maintaining a Sector Perform rating.
Analyst Frank Morgan commented, "THC exceeded expectations and the high end of guidance for 1Q18, largely driven by outperformance at Conifer through accelerated cost... More
Tenet Healthcare (THC) PT Raised to $24 at Morgan Stanley
May 2, 2018 8:02 AM EDTMorgan Stanley raised its price target on Tenet Healthcare (NYSE: THC) to $24.00 (from $16.00) while maintaining a Underweight rating.
... MoreTenet Healthcare (THC) PT Raised to $32 at SunTrust Robinson Humphrey
May 2, 2018 3:29 AM EDTSunTrust Robinson Humphrey raised its price target on Tenet Healthcare (NYSE: THC) to $32.00 (from $27.00) while maintaining a Hold rating.
... MoreTenet Healthcare (THC) PT Raised to $28 at Jefferies
May 1, 2018 1:03 AM EDTJefferies raised its price target on Tenet Healthcare (NYSE: THC) to $28.00 (from $23.00) while maintaining a Buy rating.
... More